Home NDC 73150-150 BRIUMVI
Product NDC 73150-150
11-digit product format 731500150
Labeler code 73150
Product ID 73150-150_4b34fc66-ea84-161b-e063-6294a90ac575
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ublituximab
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler TG Therapeutics, Inc.
Application BLA761238
Marketing category BLA
Marketing start 2022-12-28
Substance UBLITUXIMAB
Active strength 150 mg/6mL
Pharmacologic classes CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base BRIUMVI
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength UBLITUXIMAB 150 mg/6mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination U59UGK3IPC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2626353 Internal RxNorm lookup 2626359 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73150-150-06 BRIUMVI 6 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION, CONCENTRATE 6 21 73150-150-06 BRIUMVI 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 21
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73150-150 BRIUMVI (UBLITUXIMAB) INJECTION, SOLUTION, CONCENTRATE [TG THERAPEUTICS, INC.] 16 Current NDC, Legacy NDC, 2 package rows 20250213_3a77cd8c-811b-407c-9140-d0c5c26435c2.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761238 Briumvi ublituximab-xiiy 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 73150-150-06 73150015006 1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE 2022-12-28 0000-00-00 No No Current